Glyphosate internal dose estimation: comparing passive dosimetry and biomonitoring in simulated heavy residential herbicide application.

Authors

Daniel G Kougias, Rongcan Sun, Kenneth M Unice, Eric W Miller, Jennifer Pierce, Michael Kovochich

Published in

Arhiv za higijenu rada i toksikologiju. Volume 77. Issue 2. Pages 84-95. Jun 01, 2026. Epub Jun 30, 2026.

Abstract

Glyphosate exposure is commonly assessed using either passive dosimetry or biomonitoring. This study tests the hypothesis that internal dose estimates derived from passive dosimetry are higher and more uncertain than those derived from biomonitoring by comparing concurrently collected passive dosimetry and biomonitoring data from a controlled simulation of heavy residential herbicide application. The two predominant exposure routes were evaluated separately: six applicators were protected from dermal exposures with hooded Tyvek^® coveralls and gloves and six were protected from inhalation exposure with a respirator. Urine was serially collected from all applicators between 30 min prior to and up to 36 h after application, while breathing-zone air samplers (left and right lapel) and four dermal patches were collected from dermally protected applicators. Internal doses were independently estimated from air and dermal patch measurements (passive dosimetry) and from urinary glyphosate residues (biomonitoring; dilution-adjusted). Average total internal daily doses of glyphosate estimated from passive dosimetry were approximately seven times greater than biomonitoring-based estimates. This overestimation appeared attributable to the dermal pathway and was consistent with the uncertainty in the assumed dermal absorption and clothing penetration factors as well as with the uncertainty introduced by extrapolating a limited number of dermal patch measurements to larger body regions. Even so, the highest individual internal daily dose of glyphosate derived from passive dosimetry remained below the internal-dose benchmark derived from conservative regulatory health-based guidance values (60 µg/kg/day), suggesting a low likelihood of adverse health effects under the tested conditions. By directly comparing concurrently collected passive dosimetry and biomonitoring data in applicators with detectable urinary glyphosate, this study provides empirical support for using biomonitoring to evaluate and refine dermal passive-dosimetry assumptions in glyphosate exposure assessment.

PMID:
42398010
Bibliographic data and abstract were imported from PubMed on 04 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.